Close Menu

J Steel-Duncan

Paediatric and Perinatal HIV/AIDS in Jamaica: An International Leadership Initiative, 2002–2007

Issue: 
Pages: 
204–15

ABSTRACT

Background: Paediatric and Perinatal HIV/AIDS remain significant health challenges in the Caribbean where the HIV seroprevalence is second only to Sub-Saharan Africa.

PDF Attachment: 
Journal Sections: 
e-Published: 18 Jul, 2013

Adherence to Antiretroviral Drug Therapy in Children with HIV/AIDS in Jamaica

Issue: 
Pages: 
231–7

ABSTRACT

Objective: We aimed to describe the adherence patterns to antiretroviral therapy (ART) in a cohort of HIV-infected children.

PDF Attachment: 
Journal Sections: 
e-Published: 18 Jul, 2013

Safety of Antiretroviral Drug Therapy in Jamaican Children with HIV/AIDS

Renal Manifestations in HIV-infected Jamaican Children

Absence of Opportunistic Parasitic Infestations in Children Living with HIV/AIDS in Children’s Homes in Jamaica: Pilot Investigations

Issue: 
Pages: 
253–6

ABSTRACT

Background: Many children living with HIV/AIDS in developing countries are infected with intestinal parasites. These infections add unnecessary morbidity to children already suffering the clinical insult of living with HIV/AIDS.

Objective: To determine the prevalence and potential risk factors for intestinal parasitic infections in HIV-infected children living in two institutions in Jamaica.

PDF Attachment: 
Journal Sections: 
e-Published: 19 Jul, 2013

HIV-related Mortality in Jamaican Children

Issue: 
Pages: 
265–8

ABSTRACT

Objective: Paediatric HIV is a leading cause of morbidity and mortality worldwide. We describe HIVrelated mortality in a cohort of HIV-infected Jamaican children and identified factors which influenced survival.

PDF Attachment: 
Journal Sections: 
e-Published: 19 Jul, 2013

Bacille Calmette-Guérin Lymphadenitis and Immune Reconstitution Syndrome in HIV-infected Children on Antiretroviral Therapy in Jamaica

Issue: 
Pages: 
302–6

ABSTRACT

The immune reconstitution inflammatory syndrome (IRIS) is a recognized complication associated with opportunistic infections occurring in HIV-infected individuals after the initiation of highly active antiretroviral therapy (HAART). We report on three HIV-infected infants with rapid progressor HIV disease who present with IRIS due to the BCG vaccine and occurring 3–6 weeks after initiation of HAART.

PDF Attachment: 
Journal Sections: 
e-Published: 19 Jul, 2013
Subscribe to RSS - J Steel-Duncan
Top of Page